1. System Biosciences Announces License of ExoQuick® Technology to QIAGEN

    System Biosciences Announces License of ExoQuick® Technology to QIAGEN
    PRESS RELEASE: System Biosciences (SBI), a leading provider of exosome research tools and services, Continue reading →
  2. What’s new in exosome research? Here are a few of the recent papers we’re most excited about

    What’s new in exosome research? Here are a few of the recent papers we’re most excited about
    A roundup of the recent exosome literature highlights the therapeutic potential of stem cell-derived exosomes and the complex role of exosomes in cancer. Continue reading →

2 Item(s)